Summary
The product Trenbolone Acetate 200 mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Trenbolone Acetate, with a concentration of 189.70 mg/ml, which is 5.15% below the labeled claim of 200 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 05 November 2024. The results confirm the presence of the active ingredient, though the measured concentration is slightly lower than expected. Independent third-party testing remains essential to validate these findings and ensure consistency across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Trenbolone Acetate 200 mg
- Active Ingredient: Trenbolone Acetate
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51778
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 200 mg/ml (as stated on the label)
- Measured Concentration: 189.70 mg/ml
- Accuracy: 94.85% (5.15% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51778_1VAD34E877PP
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Trenbolone Acetate 200 mg is slightly underdosed, with a measured concentration of 189.70 mg/ml. While the presence of the active ingredient is verified, the deviation from the label claim suggests a need for improved consistency in production. Since Olympian Pharmaceutical submitted and funded the test, independent validation through third-party testing remains crucial to confirm uniformity across different batches. Additional testing would further ensure reliability and transparency in product quality.
Conclusion
The analysis confirms that Trenbolone Acetate 200 mg is slightly underdosed, with a measured concentration of 189.70 mg/ml, which is 5.15% below the labeled claim. While the active ingredient is present, this deviation underscores the importance of continued testing to maintain accurate dosing and quality control. This report is provided as an educational and harm reduction resource, helping consumers make informed choices regarding steroid-based products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it provides useful data when critically assessed alongside third-party independent results. Readers are encouraged to use this information responsibly.
